The finding that prebreakthrough plasma from VR21, VR26, VR37, and VR97 mediated strong inhibition of ACE2/spike binding with the vaccine strain isolate but weaker inhibition with the Omicron variant may suggest that boosted VRs with narrow antibody responses to the spike protein may be more susceptible to breakthrough infections with VOCs. This evidence concerns the gene ACE2 and infection.